Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Equity Ratio (2018 - 2025)

Exagen (XGN) has disclosed Equity Ratio for 8 consecutive years, with 0.3 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 40.87% year-over-year to 0.3, compared with a TTM value of 0.3 through Dec 2025, up 40.87%, and an annual FY2025 reading of 0.3, up 40.87% over the prior year.
  • Equity Ratio was 0.3 for Q4 2025 at Exagen, up from 0.29 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.74 in Q1 2021 and bottomed at 0.16 in Q1 2025.
  • Average Equity Ratio over 5 years is 0.46, with a median of 0.45 recorded in 2023.
  • Peak annual rise in Equity Ratio hit 40.87% in 2025, while the deepest fall reached 59.61% in 2025.
  • Year by year, Equity Ratio stood at 0.69 in 2021, then fell by 28.43% to 0.49 in 2022, then fell by 19.07% to 0.4 in 2023, then tumbled by 46.43% to 0.21 in 2024, then surged by 40.87% to 0.3 in 2025.
  • Business Quant data shows Equity Ratio for XGN at 0.3 in Q4 2025, 0.29 in Q3 2025, and 0.36 in Q2 2025.